• We’re currently investigating an issue related to the forum theme and styling that is impacting page layout and visual formatting. The problem has been identified, and we are actively working on a resolution. There is no impact to user data or functionality, this is strictly a front-end display issue. We’ll post an update once the fix has been deployed. Thanks for your patience while we get this sorted.

Discussion This cure may be the one Rosetta@home discovered

That's preliminary results from a clinical study of Molnupiravir which is being developed by Ridgeback Biotherapeutics and Merck. Here's the press release.

The "minipeptide(s)" discovered by University of Washington researchers using Rosetta is still in preclinical evaluation. Here's the latest information that I could find.
Is it possible that the other project took its main product/research from the Rosetta study ?
 
Is it possible that the other project took its main product/research from the Rosetta study ?
No, Rosetta is strictly used for protein/peptide engineering, etc. Molnupiravir is a small molecule drug with a different mechanism of action (viral replication inhibitor). The Rosetta minipeptide inhibits the binding of the virus to the target cell.
 
No, Rosetta is strictly used for protein/peptide engineering, etc. Molnupiravir is a small molecule drug with a different mechanism of action (viral replication inhibitor). The Rosetta minipeptide inhibits the binding of the virus to the target cell.
OK, all beyond me. It just sounded like the same thing. I guess 2 days to beat the same horse.

Thanks for the input.
 
Back
Top